Meta-Analysis of Tumor Necrosis Factor Inhibitors and Glucocorticoids on Bone Density in Rheumatoid Arthritis and Ankylosing Spondylitis Trials

Effects of Low-Dose Corticosteroids on the Bone Mineral Density of Patients With Rheumatoid Arthritis

(2016) Young Ho Lee et al.   JOURNAL OF INVESTIGATIVE MEDICINE

EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases

(2013) N Duru et al.   ANNALS OF THE RHEUMATIC DISEASES

Biologic therapies and systemic bone loss in rheumatoid arthritis

(2013) Theodoros Dimitroulas et al.   AUTOIMMUNITY REVIEWS

Effects of anti-tumor necrosis factor α agents on bone

(2012) Vivian K. Kawai et al.   CURRENT OPINION IN RHEUMATOLOGY

Inflammatory bone loss: pathogenesis and therapeutic intervention

(2012) Kurt Redlich et al.   NATURE REVIEWS DRUG DISCOVERY

A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis

(2012) S. Lekamwasam et al.   OSTEOPOROSIS INTERNATIONAL

IL-6 Receptor Inhibition Positively Modulates Bone Balance in Rheumatoid Arthritis Patients with an Inadequate Response to Anti-Tumor Necrosis Factor Therapy: Biochemical Marker Analysis of Bone Metabolism in the Tocilizumab RADIATE Study (NCT00106522)

(2012) Morten A. Karsdal et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Radiographic progression is associated with resolution of systemic inflammation in patients with axial spondylarthritis treated with tumor necrosis factor α inhibitors: A study of radiographic progression, inflammation on magnetic resonance imaging, and c

(2011) Susanne Juhl Pedersen et al.   ARTHRITIS AND RHEUMATISM

Prevalence of vertebral fractures in patients with rheumatoid arthritis: revisiting the role of glucocorticoids

(2011) M. Ghazi et al.   OSTEOPOROSIS INTERNATIONAL

2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary

(2010) A. Papaioannou et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Increased Fracture Risk in Patients with Rheumatic Disorders and Other Inflammatory Diseases -- A Case-Control Study with 53,108 Patients with Fracture

(2010) R. J. WEISS et al.   JOURNAL OF RHEUMATOLOGY

American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis

(2010) Jennifer M. Grossman et al.   ARTHRITIS CARE & RESEARCH

Infliximab therapy increases body fat mass in early rheumatoid arthritis independently of changes in disease activity and levels of leptin and adiponectin: a randomised study over 21 months

(2010) Inga-Lill Engvall et al.   ARTHRITIS RESEARCH & THERAPY

Bone loss in patients with active early rheumatoid arthritis: infliximab and methotrexate compared with methotrexate treatment alone. Explorative analysis from a 12-month randomised, double-blind, placebo-controlled study

(2009) G Haugeberg et al.   ANNALS OF THE RHEUMATIC DISEASES

Rapid and sustained improvement in bone and cartilage turnover markers with the anti–interleukin-6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: Results from a substudy of the multicenter double-blind, placebo-controlled trial of tocilizumab in inadequate responders to methotrexate alone

(2009) Patrick Garnero et al.   ARTHRITIS AND RHEUMATISM

Adalimumab therapy reduces hand bone loss in early rheumatoid arthritis: explorative analyses from the PREMIER study

(2008) M Hoff et al.   ANNALS OF THE RHEUMATIC DISEASES

Effects of infliximab on markers of inflammation and bone turnover and associations with bone mineral density in patients with ankylosing spondylitis

(2008) S Visvanathan et al.   ANNALS OF THE RHEUMATIC DISEASES

Impact of low-dose prednisolone on bone synthesis and resorption in early rheumatoid arthritis - experiences from a two-year randomized study

(2008) Inga-Lill Engvall et al.   ARTHRITIS RESEARCH & THERAPY

Changes in bone mineral density in patients with recent onset, active rheumatoid arthritis

(2007) M Guler-Yuksel et al.   ANNALS OF THE RHEUMATIC DISEASES